BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734
179582 results:

  • 1. [Fire dragon cupping in prevention and treatment of chemotherapy-induced nausea and vomiting in breast cancer: a randomized controlled trial].
    Chen Q; Lei Y; Bai S; Luo X; Lei X; Chen Y; Li D
    Zhongguo Zhen Jiu; 2024 May; 44(5):526-30. PubMed ID: 38764102
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation.
    Roesel I; Froehlich D; Joos S; Valentini J; Mauch H; Martus P
    Health Qual Life Outcomes; 2024 May; 22(1):39. PubMed ID: 38764032
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer.
    Sharma R; Yadav V; Jha S; Dighe S; Jain S
    Carbohydr Polym; 2024 Aug; 338():122196. PubMed ID: 38763723
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study.
    Gnangnon FHR; Parenté A; Aboubakar M; Kiki-Migan Y; Totah T; Gbessi DG; Tonato-Bagnan JA; Laleye A; Preux PM; Denakpo JL; Blanquet V; Houinato DS
    BMC Womens Health; 2024 May; 24(1):295. PubMed ID: 38762733
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Potential drug targets for tumors identified through Mendelian randomization analysis.
    Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
    Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Effect of gradient pressure therapy on the prevention of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
    Dongxue G; Fangfei Z; Ran L; Lizhi Z
    Support Care Cancer; 2024 May; 32(6):367. PubMed ID: 38761270
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A prospective, multicenter, randomized, double-blind placebo-controlled trial on purified and specific Cytoplasmic pollen extract for hot flashes in breast cancer survivors.
    Bounous VE; Cipullo I; D'Alonzo M; Martella S; Franchi D; Villa P; Biglia N; Ferrero A
    Gynecol Endocrinol; 2024 Dec; 40(1):2334796. PubMed ID: 38760920
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age.
    Boutrus RR; Abdelazim YA; Mohammed T; Bayomy M; Ibraheem MH; Hussein A; Sebaie ME
    BMC Cancer; 2024 May; 24(1):599. PubMed ID: 38760780
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
    Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
    BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The role of platelet rich plasma enriched fat graft for correction of deformities after conservative breast surgery.
    Shaaban A; Anwar M; Ramadan R
    Breast Dis; 2024; 43(1):111-118. PubMed ID: 38758987
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A prediction model based on digital breast pathology image information.
    Sun G; Cai L; Yan X; Nie W; Liu X; Xu J; Zou X
    PLoS One; 2024; 19(5):e0294923. PubMed ID: 38758814
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Repository of MRI-derived models of the breast with single and multiple benign and malignant tumors for microwave imaging research.
    Pelicano AC; Gonçalves MCT; Castela T; Orvalho ML; Araújo NAM; Porter E; Conceição RC; Godinho DM
    PLoS One; 2024; 19(5):e0302974. PubMed ID: 38758760
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.
    Rajan KK; Fairhurst K; Birkbeck B; Novintan S; Wilson R; Savović J; Holcombe C; Potter S
    BJS Open; 2024 May; 8(3):. PubMed ID: 38758563
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dynamic Projection of Medication Nonpersistence and Nonadherence Among Patients With Early breast cancer.
    Rinder P; Marcille T; Sinel-Boucher P; Cals-Maurette M; Kanoun D; Levy C; Teixeira L; Hornus P; Szeftel D; Heudel PE
    JAMA Netw Open; 2024 May; 7(5):e2411909. PubMed ID: 38758553
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
    Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
    Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Bcl-2 dependent modulation of Hippo pathway in cancer cells.
    D'Aguanno S; Brignone M; Scalera S; Chiacchiarini M; Di Martile M; Valentini E; De Nicola F; Ricci A; Pelle F; Botti C; Maugeri-Saccà M; Del Bufalo D
    Cell Commun Signal; 2024 May; 22(1):277. PubMed ID: 38755629
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. D-arabinose induces cell cycle arrest by promoting autophagy via p38 MAPK signaling pathway in breast cancer.
    Tang Z; Song H; Qin S; Tian Z; Zhang C; Zhou Y; Cai R; Zhu Y
    Sci Rep; 2024 May; 14(1):11219. PubMed ID: 38755221
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
    Salim N; Tumanova K; Popodko A; Libson E
    JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Interaction of sedentary behaviour and educational level in breast cancer risk.
    Pinto-Carbó M; Vanaclocha-Espí M; Ibañez J; Martín-Pozuelo J; Romeo-Cervera P; Nolasco A; Besó-Delgado M; Castán-Cameo S; Salas D; Molina-Barceló A
    PLoS One; 2024; 19(5):e0300349. PubMed ID: 38753623
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Determinants and Factors of Physical Activity After Oncology Treatments (DEFACTO) in Metropolitan France: Protocol of a Mixed Methods Study and Intervention.
    Aumaitre A; Gagnayre R; Foucaut AM
    JMIR Res Protoc; 2024 May; 13():e52274. PubMed ID: 38753415
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8980.